- E-postKalland@uib.no
- Telefon+47 55 58 45 06+47 953 30 352
- BesøksadresseHaukeland universitetssykehus, Laboratoriebygget5009 Bergen
- PostadressePostboks 78045020 Bergen
Vitenskapelig artikkel
- (2023). GM-CSF, Flt3-L and IL-4 affect viability and function of conventional dendritic cell types 1 and 2. Frontiers in Immunology.
- (2022). Proteasome‐mediated regulation of GATA2 expression and androgen receptor transcription in benign prostate epithelial cells. Biomedicines. 14 sider.
- (2022). Novel STAT3 Inhibitors Targeting STAT3 Dimerization by Binding to the STAT3 SH2 Domain. Frontiers in Pharmacology. 15 sider.
- (2021). Evaluation of β-catenin inhibition of axitinib and nitazoxanide in human monocyte-derived dendritic cells. Biomedicines. 1-18.
- (2020). Dual pro- and anti-inflammatory features of monocyte-derived dendritic cells. Frontiers in Immunology. 1-15.
- (2019). PIK3CA amplification associates with aggressive phenotype but not markers of AKT-mTOR signaling in endometrial carcinoma. Clinical Cancer Research. 334-345.
- (2018). Small molecule promotes β-catenin citrullination and inhibits Wnt signaling in cancer. Nature Chemical Biology. 94-101.
- (2018). Screening for viral nucleic acids in vestibular schwannoma. Journal of Neurovirology. 730-737.
- (2018). Identification of highly connected and differentially expressed gene subnetworks in metastasizing endometrial cancer. PLOS ONE. 1-21.
- (2018). Dual androgen receptor (AR) and STAT3 inhibition by a compound targeting the AR amino-terminal domain. Pharmacology Research & Perspectives. 1-15.
- (2017). Tumour-associated glial host cells display a stem-like phenotype with a distinct gene expression profile and promote growth of GBM xenografts. BMC Cancer. 1-13.
- (2017). Proteomic profiling of endometrioid endometrial cancer reveals differential expression of hormone receptors and MAPK signaling proteins in obese versus non-obese patients. OncoTarget. 106989-107001.
- (2017). PIK3CA exon9 mutations associate with reduced survival, and are highly concordant between matching primary tumors and metastases in endometrial cancer. Scientific Reports. 1-12.
- (2017). HER2 expression patterns in paired primary and metastatic endometrial cancer lesions. British Journal of Cancer. 378-387.
- (2017). An androgen response element driven reporter assay for the detection of androgen receptor activity in prostate cells. PLOS ONE. 1-20.
- (2016). Expression of circadian clock genes and proteins in urothelial cancer is related to cancer-associated genes. BMC Cancer. 17 sider.
- (2016). Context dependent regulatory patterns of the androgen receptor and androgen receptor target genes. BMC Cancer. 15 sider.
- (2016). Axitinib blocks Wnt/β-catenin signaling and directs asymmetric cell division in cancer. Proceedings of the National Academy of Sciences of the United States of America. 9339-9344.
- (2016). Aneuploidy related transcriptional changes in endometrial cancer link low expression of chromosome 15q genes to poor survival. OncoTarget. 9696-9707.
- (2016). Androgen receptor as potential therapeutic target in metastatic endometrial cancer. OncoTarget. 49289-49298.
- (2015). Tumor necrosis is an important hallmark of aggressive endometrial cancer and associates with hypoxia, angiogenesis and inflammation responses. OncoTarget. 39676-39691.
- (2015). Molecular profiling of endometrial carcinoma precursor, primary and metastatic lesions suggests different targets for treatment in obese compared to non-obese patients. OncoTarget. 1327-1339.
- (2015). Increased angiogenesis is associated with a 32-gene expression signature and 6p21 amplification in aggressive endometrial cancer. OncoTarget. 10634-10645.
- (2015). ATAD2 overexpression links to enrichment of B-MYBtranslational signatures and development of aggressive endometrial carcinoma. OncoTarget. 28440-28452.
- (2014). Switch in FOXA1 status associates with endometrial cancer progression. PLOS ONE.
- (2014). Spontaneous reversion of the angiogenic phenotype to a nonangiogenic and dormant state in human tumors. Molecular Cancer Research. 754-764.
- (2014). Hypomethylation of the CTCFL/BORIS promoter and aberrant expression during endometrial cancer progression suggests a role as an Epi-driver gene. OncoTarget. 1052-1061.
- (2014). High level of HSF1 associates with aggressive endometrial carcinoma and suggests potential for HSP90 inhibitors. British Journal of Cancer. 78-84.
- (2014). Endometrial Carcinoma Recurrence Score (ECARS) validates to identify aggressive disease and associates with markers of epithelial-mesenchymal transition and PI3K alterations. Gynecologic Oncology. 599-606.
- (2013). p63 attenuates epithelial to mesenchymal potential in an experimental prostate cell model. PLOS ONE. 12 sider.
- (2013). MiR-182 and miR-203 induce mesenchymal to epithelial transition and self-sufficiency of growth signals via repressing SNAI2 in prostate cells. International Journal of Cancer. 544-555.
- (2013). Lack of estrogen receptor-alpha is associated with epithelial-mesenchymal transition and PI3K alterations in endometrial carcinoma. Clinical Cancer Research. 1094-1105.
- (2013). Integrated genomic analysis of the 8q24 amplification in endometrial cancers identifies ATAD2 as essential to MYC-dependent cancers. PLOS ONE. 9 sider.
- (2013). High phospho-stathmin(Serine38) expression identifies aggressive endometrial cancer and suggests an association with PI3K inhibition. Clinical Cancer Research. 2331-2341.
- (2013). Generation of prostate tumor-initiating cells is associated with elevation of reactive oxygen species and IL-6/STAT3 signaling. Cancer Research. 7090-7100.
- (2013). Gene set based integrated data analysis reveals phenotypic differences in a brain cancer model. PLOS ONE. 11 sider.
- (2013). Differences in proliferative capacity of primary human acute myelogenous leukaemia cells are associated with altered gene expression profiles and can be used for subclassification of patients. Cell Proliferation. 554-562.
- (2013). ARID1A loss is prevalent in endometrial hyperplasia with atypia and low-grade endometrioid carcinomas. Modern Pathology. 428-434.
- (2012). Suppression of heat shock protein 27 induces long-term dormancy in human breast cancer. Proceedings of the National Academy of Sciences of the United States of America. 8699-8704.
- (2012). Loss of GPER identifies new targets for therapy among a subgroup of ER alpha-positive endometrial cancer patients with poor outcome. British Journal of Cancer. 1682-1688.
- (2012). Lipocalin 2 expression is associated with aggressive features of endometrial cancer. BMC Cancer. 7 sider.
- (2012). KRAS gene amplification and overexpression but not mutation associates with aggressive and metastatic endometrial cancer. British Journal of Cancer. 1997-2004.
- (2012). High-throughput mutation profiling of primary and metastatic endometrial cancers identifies KRAS, FGFR2 and PIK3CA to be frequently mutated. PLOS ONE.
- (2012). Gene expression in tumor cells and stroma in dsRed 4T1 tumors in eGFP-expressing mice with and without enhanced oxygenation. BMC Cancer. 10 sider.
- (2011). Transcribed DNA is preferentially located in the perichromatin region of mammalian cell nuclei. Experimental Cell Research. 433-444.
- (2011). Reprogramming of cell junction modules during stepwise epithelial to mesenchymal transition and accumulation of malignant features in vitro in a prostate cell model. Experimental Cell Research. 234-247.
- (2011). High BMI is significantly associated with positive progesterone receptor status and clinico-pathological markers for non-aggressive disease in endometrial cancer. British Journal of Cancer. 921-926.
- (2011). Gene Expression Patterns Related to Vascular Invasion and Aggressive Features in Endometrial Cancer. American Journal of Pathology. 861-871.
- (2011). Amplification of the 20q chromosomal arm occurs early in tumorigenic transformation and may initiate cancer. PLOS ONE. 15 sider.
- (2010). Primary human acute myelogenous leukemia cells release matrix metalloproteases and their inhibitors: release profile and pharmacological modulation. European Journal of Haematology. 239-251.
- (2010). Global profiling of histone and DNA methylation reveals epigenetic-based regulation of gene expression during epithelial to mesenchymal transition in prostate cells. BMC Genomics. 15 sider.
- (2009). TMPRSS2:ERG fusion transcripts in urine from prostate cancer patients correlate with a less favorable prognosis. APMIS - Journal of Pathologiy, Microbiology and Immunology. 575-582.
- (2009). Primary human acute myeloid leukaemia cells increase the proliferation of microvascular endothelial cells through the release of soluble mediators. British Journal of Haematology. 53-68.
- (2009). Primary human acute myelogenous leukemia cells release matrix metalloproteases and their inhibitors; release profile and pharmacological modulaion. European Journal of Haematology. 239-251.
- (2009). Phase II study of subcutaneous alemtuzumab without dose escalation in patients with advanced-stage, relapsed chronic lymphocytic leukaemia. British Journal of Haematology. 53-68.
- (2009). Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation. Proceedings of the National Academy of Sciences of the United States of America. 4834-4839.
- (2009). Hyperoxic treatment induces mesenchymal to epithelial transition in a rat adenocarcinoma model. PLOS ONE.
- (2009). Highly infiltrative brain tumours show reduced chemosensitivity associated with a stem cell-like phenotype. Neuropathology and Applied Neurobiology. 380-393.
- (2009). Genome-wide profiling of histone H3 lysine 4 and lysine 27 trimethylation reveals an epigenetic signature in prostate carcinogenesis. PLOS ONE. 14 sider.
- (2009). Genes of cell-cell interactions, chemotherapy detoxification and apoptosis are induced during chemotherapy of acute myeloid leukemia. BMC Cancer.
- (2009). Cytokines are produced locally by myocytes in rat skeletal muscle during endotoxemia. American Journal of Physiology. Heart and Circulatory Physiology. H735-H744.
- (2008). WDR19 expression is increased in prostate cancer compared with normal cells, but low-intensity expression in cancers is associated with shorter time to biochemical failures and local recurrence. Clinical Cancer Research. 1397-1406.
- (2008). Release of angiopoietin-1 by primary human acute myelogenous leukemia cells is associated with mutations of nucleophosmin, increased by bone marrow stromal cells and possibly antagonized by high systemic angiopoietin-2 levels. Leukemia. 287-293.
- (2008). Low BMI-1 expression is associated with an activated BMI-1-driven signature, vascular invasion, and hormone receptor loss in endometrial carcinoma. British Journal of Cancer. 1662-1669.
- (2008). Epithelial to Mesenchymal Transition of a Primary Prostate Cell Line with Switches of Cell Adhesion Modules but without Malignant Transformation. PLOS ONE.
- (2007). Subclassification of patients with acute myelogenous leukemia based on chemokine responsiveness and constitutive chemokine release by their leukemic cells. Haematologica. 332-341.
- (2007). Increased expression of sim2-s protein is a novel marker of aggressive prostate cancer. Clinical Cancer Research. 892-897.
- (2007). Hyperoxia retards growth and induces apoptosis, changes in vascular density and gene expression in transplanted gliomas in nude rats. Journal of Neuro-Oncology. 191-202.
- (2007). Functional characteristics and gene expression profiles of primary acute myeloid leukamia cells indentify patient subgroups that differ susceptibility to histone deactylase inhibitors. International Journal of Oncology. 1529-1538.
- (2007). ERG upregulation and related ETS transcription factors in prostate cancer. International Journal of Oncology. 19-32.
- (2007). Comparison of nucleic acid targets prepared from total RNA or poly(A) RNA for DNA oligonucleotide microarray hybridization. Analytical Biochemistry. 46-58.
- (2006). cDNA microarray analysis of non-selected cases of acute myeloid leukemia demonstrates distinct clustering independent of cytogenetic aberrations and consistent with morphological signs of differentiation. International Journal of Oncology. 1065-1080.
- (2006). Stress-induced in vitro apoptosis of native human acute myelogenous leukemia (AML) cells shows a wide variation between patients and is associated with low BCL-2 : Bax ratio and low levels of heat shock protein 70 and 90. Leukemia Research. 1531-1540.
- (2006). Angiogenesis-independent tumor growth mediated by stem-like cancer cells. Proceedings of the National Academy of Sciences of the United States of America. 16466-16471.
- (2006). A distinct p53 protein isoform signature reflects the onset of induction chemotherapy for acute myeloid leukemia. Clinical Cancer Research. 3985-3992.
- (2005). Nucleic-acid based diagnostics in clinical microbiology. Tidsskrift for Den norske legeforening. 3110-3114.
- (2005). Gene expression profiles in prostate cancer: Association with patient subgroups and tumour differentiation. International Journal of Oncology. 329-336.
- (2005). CD34 expression in native human acute myelogenous leukemia blasts: Differences in CD34 membrane molecule expression are associated with different gene expression profiles. Cytometry. 18-27.
- (2003). Cellular localisation and nuclear export of the human bZIP transcription factor TCF11. Biochimica et Biophysica Acta. 143-151.
- (2002). Rev inhibition strongly affects intracellular distribution of HIV-1 RNAs. Journal of Virology. 10473-10484.
- (2002). Nuclear import of factors involved in signaling is inhibited in C3H/10T1/2 cells treated with tetradecylthioacetic acid. Journal of Lipid Research. 1630-1640.
- (2002). Analysis of acute myelogenous leukemia: preparation of samples for genomic and proteomic analyses. Journal of Hematotherapy & Stem Cell Research. 469-481.
- (2001). Mitochondrial protein p32 can accumulate in the nucleus. Biochemical and Biophysical Research Communications - BBRC. 1161-1169.
- (2000). Identification of a nuclear ribonucleoprotein particle which contains incompletely spliced HIV-1 RNAs. Biochemical and Biophysical Research Communications - BBRC. 509-513.
- (1999). Nukleinsyrebasert mikrobiolgoisk diagnostikk. Tidsskrift for Den norske legeforening. 802-809.
- (1999). Co-expression of a trans-dominant negative mutant of the human immunodeficiency virus type 1 (HIV-1) Rev protein affects the Rev-dependent splicing pattern and expression of HIV-1 RNAs. Journal of General Virology. 1965-1974.
- (1999). A trans-dominant negative mutant of the HIV-1 Rev protein affects the Rev-dependent splicing pattern and expression of HIV RNA. Journal of General Virology. 1965-1974.
- (1998). Visualisation of ribosomal RNA (rRNA) synthesis in eukaryotic cells in culture. Methods in Cell Science. 295-302.
- (1998). Subcellular localization of human immunodeficiency virus type 1 RNAs, Rev, and the splicing factor SC-35. Virology. 473-482.
- (1998). Labelling of eukaryotic RNA transcripts with BrUTP using liposomal (DOTAP) and non-liposomal (FuGENE 6) transfection reagents: new application for transfection reagents. Biochemica. 45-46.
- (1998). Histographic recording of human immunodeficiency virus type 1 (HIV-1) regulatory protein Rev and nuclear factors. APMIS - Journal of Pathologiy, Microbiology and Immunology. 623-635.
- (1997). Oligomerization of HIV-1 Rev mutants in the cytoplasm and during nuclear import. Virology. 73-81.
- (1997). Labelling of RNA transcripts of eukaryotic cells in culture with Br UTP using a liposome transfection reagent (DOTAP). BioTechniques. 308-312.
- (1996). Immunoglobin G sublass antibodies to rubella viruses in chronic liver disease, acute rubella and healthy controls. FEMS Immunology and Medical Microbiology. 43-50.
- (1996). HIV-1 proviral DNA sequences of env PCR amplificates from Tanzania. APMIS - Journal of Pathologiy, Microbiology and Immunology. 459-464.
- (1995). Raised levels of antibodies to human viruses at the clinical onset of autoimmune chronic active hepatitis. Journal of Viral Hepatitis. 159-164.
- (1995). Nuclear export of the human immunodeficiency virus type 1 nucleocytoplasmic shuttle protein Rev is mediated by its activation domain and is blocked by transdominant negative mutants. Journal of Virology. 3315-3323.
- (1994). Viral antibodies in infectious mononucleosis. FEMS Immunology and Medical Microbiology. 219-224.
- (1994). Radioimmunoprecipitation and immunoblot studies of antibodies to rubella virus in patients with chronic liver disease. Archives of Virology. 73-85.
- (1994). Elevated rubella antibodies in patients with chronic liver diseases. Journal of Medical Virology. 30-36.
- (1993). Diagnosis of infection with human T-cell lymphotropic virus type 2 (HTL V-2) in Norwegian HIV infected individuals. Clinical and Diagnostic Virology. 143-152.
- (1991). Viral RNA species in cell lines persistently and lytically infected with measles virus. APMIS - Journal of Pathologiy, Microbiology and Immunology. 42-48.
- (1991). Study of transcription in measles virus infected Vero cells using cDNA probes prepared from poly(A)RNA from uninfected and infected cells. APMIS - Journal of Pathologiy, Microbiology and Immunology. 33-41.
- (1991). Rex-dependent nucleolar accumulation of HTLV-1 mRNA. The New Biologist. 389-397.
- (1991). Replication of HIV-1 in primary dendritic cell cultures. Proceedings of the National Academy of Sciences of the United States of America. 7998-8002.
- (1991). Presence of cfaD-homologous sequences and expression of coli surface antigen 4 on enterotoxigenic Escherichia coli; relevance for diagnostic procedures. Microbial Pathogenesis. 297-304.
- (1990). Applications of Magnetic Beads With Covalently Attached Oligonucleotides in Hybridization: Isolation and Detection of Specific Measles Virus mRNA from Crude Cell Lysate. Analytical Biochemistry. 40-50.
- (1989). Mechanism of spontaneous loss of heat-stable toxin (STa) Production in enterotoxigenic Escherichia coli. APMIS - Journal of Pathologiy, Microbiology and Immunology. 436-440.
- (1988). Comparative Study of Colony Hybridization With Synthetic Oligonucleotide Probes and Enzyme-Linked Immunosorbent Assay for Identification of Enterotoxigenic Escherichia Coli. Journal of Clinical Microbiology. 530-534.
Faglig foredrag
- (2022). SARS-Cov-2 - virusevolusjon og immunrespons.
- (2022). Enhanced cryoimmunotherapy of urogenital cancers.
- (2021). Virologisk evolusjon og immunrespons.
- (2021). SARS-Cov-2 - virusevolusjon og immunrespons.
Populærvitenskapelig foredrag
- (2022). Ny kreftbehandling i Bergen.
- (2022). Enhanced cryoimmunotherapy against urogenital cancers.
- (2022). Cryoimmunterapi som ny kreftbehandling.
- (2022). Cryoimmunterapi som ny kreftbehandling.
- (2022). Cryoimmunterapi som ny kreftbehandling.
- (2020). Utvikling og fremskritt i kreftforskning og kreftbehandling .
- (2007). Virus og kreft.
- (2005). Overexpression of ERG and SIM2 transcription factors in prostate cancer.
Vitenskapelig foredrag
- (2022). FLT3L and GM-CSF improve conventional dendritic cell viability and function.
- (2009). Genome-wide profiling of histone H3 lysine 4 and lysine 27 trimethylation reveals an epigenetic signature in prostate carcinogenesis.
- (2009). EMT Promotes Malignant Transformation of Prostate Epithelial Cells in Culture.
- (2009). A novel cell culture model of prostate carcinogenesis and its utility in phenotypic screening of small molecular compounds.
- (2008). Targeting master regulatory mechanisms in cancer therapy using novel small molecular compounds – basic mechanisms, in vitro and in vivo screening and development towards the clinic.
- (2008). Regulatory patterns of prostate carcinogenesis and development of a cell culture experimental system.
- (2008). Polycomb group target genes and bivalent H3K4 & K27me3 modifications in human embryonic cells were enriched among dysregulated genes in prostate cancer.
- (2008). Epithelial to mesenchymal transition of a primary, immortalized prostate cell line is associated with gene expression switches of entire cell attachment modules.
- (2007). Functional oncogenomics and epigenomics analysis of prostate cancer.
- (2007). Detection of TMPRSS2:ERG translocations in the urine of prostate cancer patients and identification of ERG target genes.
- (2006). The early gene expression signature of acute myeloid leukemia (AML) blasts during in vivo chemotherapy.
- (2006). The early gene expression signature of acute myeloid leukemia (AML) blasts during in vivo chemotherapy.
- (2006). Global gene expression analysis of transcription factors in prostate cancer and cell lines.
- (2006). ERG upregulation in relation to other transcription factors in prostate cancer.
- (2006). ERG upregulation and related transcription factors in prostate cancer.
- (2005). Overexpression of ERG and SIM2 transcription factors in prostate cancer.
- (2005). Onkogene, hepatotrope virus – molekylære mekanismer ved utvikling av hepatocellulært carcinom (HCC).
- (2005). Nuclear localization of active genes and their transcripts.
- (2005). Discovering candidate genes that distinguish between CML and AML using microarrays.
- (2004). Virus and cancer models.
- (2004). Real time quantitative PCR and hepatitis C monitoring.
- (2004). Global analysis of gene expression and regulatory modules in cancer tissue.
- (2004). Gene expression profiling in prostate cancer refined by pairwise comparisons of cDNA microarrays from benign and malignant tissue.
- (2004). Gene expression profiles in prostate cancer: identification of upregulated SIM2 gene validated in archival tissue, relation to histological grading and prognosis.
- (2003). Virus og Cancer.
- (2003). Global analysis of gene expression and regulatory patterns in urogenital tumours using DNA microarrays.
- (2003). Global analysis of gene expression and regulatory patterns in cancer.
- (2003). Global analysis of gene expression and regulatory patterns in acute myeloid leukemia.
- (2003). Gene expression profiling in prostate cancer: cluster analysis and association with tumor differentation.
- (2003). Gene expression profiling in prostate cancer.
- (2003). Comparison of DNA microarray and real time quantitative PCR for quantitation of gene expression of selected genes in prostate cancer.
- (2001). Global gene expression profiling using DNA microarrays - pitfalls and outlook.
- (2001). Global analysis of gene expression in human cancer.
- (2001). Angiostatin release from alginate encapsulated 293-cells.
Anmeldelse
- (2007). Immunologiske refleksjonar - "Defending Life" av Elling Ulvestad, London - Springer forlag ISBN 978-1-4020-5675-8. Tidsskrift for Den norske legeforening. 3298-3299.
Populærvitenskapelig artikkel
- (1998). HIV som modellsystem til forståing av genekspresjon. Naturen. 67-77.
Kronikk
- (1993). HTLV-I-infeksjon i Norge. Natl Inst Publ Health Rep (MSIS).
Doktorgradsavhandling
- (2018). Regulatory patterns in prostate cell differentiation – investigation of transcription factors AR, GATA2 and NKX3-1.
- (2017). Context dependent transcription factor regulation in normal and malignant cell differentiation.
- (1989). Studies on measles virus in lytic and persistent infections ; Construction and use of measles virus specific nucleic acid probes.
Intervju
- (2013). Til hjelp for andre i 40 år - Tordis og Fritz C. Riebers legat 1973 - 2013.
- (2013). Omprogrammerer celler - utforsker nye angrepsmål ved prostatakreft.
- (2008). Verdens Gang - Professorat betalt av GlaxoSmithKline ved Universitetet i Bergen.
- (2008). Bergens Tidende - Vil ha DNA-lab i Bergen.
- (2007). Livmorhalskreft.
- (2005). Legionella og andre bakterier.
- (2005). Gades Institutt - presentasjon.
- (2005). Gades Institutt - presentasjon.
- (2003). Bakterier og virus - slik beskytter du deg.
- (2001). Bakterier og virus.
Vitenskapelig Kapittel/Artikkel/Konferanseartikkel
- (2017). Models of Tumor Progression in Prostate Cancer. 16 sider.
- (2009). Molecular Microbiological Diagnostics.
- (1998). Mikrobiologisk diagnostikk. Kapittel om Nukleinsyrebasert diagnostikk.
- (1991). Retroviral regulatory proteins and the nucleolus. 14 sider.
- (1991). HIV-1 infection of human dendritic cells. 15 sider.
Sammendrag/abstract
- (2013). FOXA1 LOSS IN ENDOMETRIAL CANCER IS ASSOCIATED WITH POOR PROGNOSIS AND ER ALPHA LOSS. International Journal of Gynecological Cancer. 1 sider.
- (2012). Estrogen receptor a loss in endometrial carcinoma is associated with epithelial-to-mesenchymal transition and a potential for PI3Kinase inhibition. Virchows Archiv. S18-S18.
- (2011). TUMOR-ASSOCIATED GLIAL CELLS PROMOTE GROWTH OF GBM XENOGRAFTS IN EGFP NOD/SCID MICE. Neuro-Oncology. 55-55.
- (2009). PRIMARY HUMAN ACUTE MYELOGENOUS LEUKEMIA CELLS SHOW CONSTITUTIVE RELEASE OF SEVERAL MATRIX METALLOPROTEASES AND THEIR INHIBITORS. Haematologica. 545-545.
- (2007). Release of angiopoietin-1 by acute myelogenous leukemia (AML) cells is increased by stromal cells and associated with mutations in the nucleophosmin (NPM) gene. Experimental Hematology. 72-72.
- (2007). Linking susceptibility to histone deactylase inhibitors and basal gene expression profiles in acute myeloid leukaemia. Experimental Hematology. 77-77.
- (2007). Functional characteristics and gene expression profiles of primary acute myeloid leukaemia cells identify patient subgroups that differ in the susceptibility to histone deacetylase inhibitors. Haematologica. 112-112.
- (2006). cDNA microarray analysis of non-selected cases of acute myeloid leukemia demonstrates distinct clustering independent of cytogenetic aberrations and consistent with morphological signs of differentiation. NBS-nytt. 106.
- (2006). The early gene expression signature of acute myeloid leukemia (AML) blasts during in vivo chemotherapy. International Journal of Molecular Medicine. S65.
- (2006). Global gene expression analysis of transcription factors in prostate cancer and cell lines. International Journal of Molecular Medicine. S27.
- (2006). ERG upregulation in relation to other transcription factors in prostate cancer. NBS-nytt. 72.
- (2005). Single-minded 2 homolog gene is overexpressed in prostate cancer. Virchows Archiv. 432-432.
- (2005). Overexpression of ERG and SIM2 transcription factors in prostate cancer. International Journal of Molecular Medicine. S76-S76.
Vitenskapelig oversiktsartikkel/review
- (2021). Liquid Biopsies in Solid Cancers: Implementation in a Nordic Healthcare System . Cancers. 17 sider.
- (2018). Targeting Wnt/β-catenin signaling for cancer immunotherapy. TIPS - Trends in Pharmacological Sciences. 648-658.
- (2009). Tumor virology - history, status and future challenges. APMIS - Journal of Pathologiy, Microbiology and Immunology. 382-399.
- (2007). Global gene expression in classification, pathogenetic understanding and identification of therapeutic targets in Acute Myeloid Leukemia. Current Pharmaceutical Biotechnology. 344-354.
- (2007). Early gene expression of acute myeloid leukemia in response to chemotherapy. Expert Review of Anticancer Therapy. 741-751.
Brosjyre
- (2021). CCBIO Annual Report 2020 - Prostate Cancer Therapy Research Group p. 36.
- (2021). CCBIO Annual Report 2020 - CryoIT pp. 22-23.
- (2020). Newsletter CryoIT Desember 2020.
Faglig kapittel
- (2022). Models of Tumor Progression in Prostate Cancer. 453-466. I:
- (2022). Biomarkers of the Tumor Microenvironment. Springer.
- (2019). Hepatittvirus. 340-344. I:
- (2019). Medisinsk mikrobiologi. Gyldendal Akademisk.
- (2009). Molecular microbial diagnostics. 336-364. I:
- (2009). Molecular Biology and Biotechnology 5th Ed. Springer.